Keber I - Search Results

1

Tissue plasminogen activator release in chronic venous hypertension due to heart failure.

Keber I, Keber D, Stegnar M, Vene N. Keber I, et al. Among authors: keber d. Thromb Haemost. 1992 Sep 7;68(3):321-4. Thromb Haemost. 1992. PMID: 1440498

2

Prognostic impact of haemostatic derangements in chronic heart failure.

Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I. Jug B, et al. Among authors: keber i. Thromb Haemost. 2009 Aug;102(2):314-20. doi: 10.1160/TH08-11-0721. Thromb Haemost. 2009. PMID: 19652882

3

Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.

Keber D, Stegnar M, Keber I, Accetto B. Keber D, et al. Among authors: keber i. Thromb Haemost. 1979 Jun 30;41(4):745-55. Thromb Haemost. 1979. PMID: 483247

4

Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis.

Keber I, Keber D. Keber I, et al. Among authors: keber d. Haemostasis. 1992;22(4):187-94. doi: 10.1159/000216318. Haemostasis. 1992. PMID: 1468721

5

Procoagulant state in heart failure with preserved left ventricular ejection fraction.

Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I. Jug B, et al. Among authors: keber i. Int Heart J. 2009 Sep;50(5):591-600. doi: 10.1536/ihj.50.591. Int Heart J. 2009. PMID: 19809208 Free article.

6

Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors.

Sebestjen M, Keber I, Zegura B, Simcic S, Bozic M, Fressart MM, Stegnar M. Sebestjen M, et al. Among authors: keber i. Thromb Haemost. 2004 Nov;92(5):1129-35. doi: 10.1160/TH03-04-0250. Thromb Haemost. 2004. PMID: 15543343 Clinical Trial.

7

Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity.

Keber I, Jereb M, Keber D. Keber I, et al. Among authors: keber d. Thromb Res. 1987 Apr 15;46(2):205-12. doi: 10.1016/0049-3848(87)90282-9. Thromb Res. 1987. PMID: 3111000

8

No significant effect of chronic aspirin use on fibrinolytic response to venous occlusion in coronary patients.

Keber I, Keber D. Keber I, et al. Among authors: keber d. Thromb Res. 1985 Sep 15;39(6):761-5. doi: 10.1016/0049-3848(85)90260-9. Thromb Res. 1985. PMID: 3936224 No abstract available.

9

Carotid intima-media thickness of young coronary patients.

Vrtovec B, Keber I, Gadzijev A, Bardorfer I, Keber D. Vrtovec B, et al. Among authors: keber d, keber i. Coron Artery Dis. 1999 Sep;10(6):407-11. doi: 10.1097/00019501-199909000-00010. Coron Artery Dis. 1999. PMID: 10474792

10

Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease.

Mavri A, Guzic-Salobir B, Salobir-Pajnic B, Keber I, Stare J, Stegnar M. Mavri A, et al. Among authors: keber i. Blood Coagul Fibrinolysis. 2001 Jul;12(5):359-65. doi: 10.1097/00001721-200107000-00004. Blood Coagul Fibrinolysis. 2001. PMID: 11505078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters